Fast-Track

Executive Summary

Fast-Track Drugs and Biologics, LLC is a contract research organization (CRO) based in Cambridge, MA, specializing in strategic planning, clinical trial management, and regulatory support for the development of vaccines and therapeutics. Founded in 2008, the company serves pharmaceutical and biotech clients navigating the complex landscape of preclinical through commercial stages. Fast-Track’s expertise in drug delivery and small molecules positions it as a partner for both early-stage and established firms seeking to accelerate development timelines and improve regulatory outcomes. Despite being in a competitive CRO market, Fast-Track’s focus on vaccines and biologics aligns with growing global demand. However, as a private entity with no disclosed pipeline or funding, its financial performance and client portfolio remain opaque, warranting a cautious assessment of near-term value.

Upcoming Catalysts (preview)

• Q3 2026Announcement of Major Contract Win with Vaccine Developer60% success
• Q4 2026Regulatory Filing Support Milestone for Client Candidate50% success
• TBDExpansion of Service Offerings into Gene Therapy CRO30% success